Literature DB >> 8877076

EUK-8 a synthetic catalytic scavenger of reactive oxygen species protects isolated iron-overloaded rat heart from functional and structural damage induced by ischemia/reperfusion.

S Pucheu1, F Boucher, T Sulpice, N Tresallet, Y Bonhomme, B Malfroy, J de Leiris.   

Abstract

The effects of EUK-8, a synthetic, catalytic scavenger of reactive oxygen species, on isolated iron-overloaded rat hearts submitted to ischemia-reperfusion were studied. In the absence of EUK-8, functional parameters (systolic and diastolic pressures, oxygen consumption as estimated by the product heart rate times left ventricular diastolic pressure) were severely impaired 1 minute and 15 minutes after reperfusion following a 15 minute ischemic episode. Dimethylthiourea (10 mM), a hydroxyl radical scavenger, had a minimally protective effect. In contrast, EUK-8 at a concentration of 50 microM in the perfusion medium maintained these parameters at close to their preischemia values. Electron microscopic analysis of heart tissues after 15 minutes ischemia followed by 15 minutes reperfusion showed extensive damage to mitochondria and sarcomeres in untreated hearts, while the extent of damage was significantly lower in EUK-8-treated hearts. The functional and structural protection afforded by EUK-8 were significantly better than those induced by dimethylthiourea. These data suggest that EUK-8 may be therapeutically useful in preventing heart damage induced by ischemia-reperfusion, for example, during thrombolytic treatment of myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877076     DOI: 10.1007/bf02627957

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  35 in total

1.  Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts.

Authors:  G Ambrosio; J T Flaherty; C Duilio; I Tritto; G Santoro; P P Elia; M Condorelli; M Chiariello
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 2.  Reperfusion injury and its pharmacologic modification.

Authors:  L H Opie
Journal:  Circulation       Date:  1989-10       Impact factor: 29.690

3.  The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction.

Authors:  R Bolli; B S Patel; W X Zhu; P G O'Neill; C J Hartley; M L Charlat; R Roberts
Journal:  Am J Physiol       Date:  1987-12

Review 4.  Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.

Authors:  R A Kloner; K Przyklenk; P Whittaker
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

5.  EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine.

Authors:  P K Gonzalez; J Zhuang; S R Doctrow; B Malfroy; P F Benson; M J Menconi; M P Fink
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

6.  Salen-manganese complexes are superoxide dismutase-mimics.

Authors:  M Baudry; S Etienne; A Bruce; M Palucki; E Jacobsen; B Malfroy
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

7.  Iron availability and free radical induced injury in the isolated ischaemic/reperfused rat heart.

Authors:  E Karwatowska-Prokopczuk; E Czarnowska; A Beresewicz
Journal:  Cardiovasc Res       Date:  1992-01       Impact factor: 10.787

8.  An improved perfusion apparatus for small animal hearts.

Authors:  M J Curtis; B A Macleod; R Tabrizchi; M J Walker
Journal:  J Pharmacol Methods       Date:  1986-02

9.  Ultrastructural morphometric analysis of myocardium from dogs, rats, hamsters, mice, and from human hearts.

Authors:  J Schaper; E Meiser; G Stämmler
Journal:  Circ Res       Date:  1985-03       Impact factor: 17.367

10.  Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart.

Authors:  N E Farber; G M Vercellotti; H S Jacob; G M Pieper; G J Gross
Journal:  Circ Res       Date:  1988-08       Impact factor: 17.367

View more
  9 in total

Review 1.  Mitochondria and cardiovascular diseases-from pathophysiology to treatment.

Authors:  Gerasimos Siasos; Vasiliki Tsigkou; Marinos Kosmopoulos; Dimosthenis Theodosiadis; Spyridon Simantiris; Nikoletta Maria Tagkou; Athina Tsimpiktsioglou; Panagiota K Stampouloglou; Evangelos Oikonomou; Konstantinos Mourouzis; Anastasios Philippou; Manolis Vavuranakis; Christodoulos Stefanadis; Dimitris Tousoulis; Athanasios G Papavassiliou
Journal:  Ann Transl Med       Date:  2018-06

Review 2.  Mitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseases.

Authors:  Thekkuttuparambil Ananthanarayanan Ajith; Thankamani Gopinathan Jayakumar
Journal:  World J Cardiol       Date:  2014-10-26

Review 3.  Mitochondrial biogenesis: regulation by endogenous gases during inflammation and organ stress.

Authors:  Hagir B Suliman; Claude A Piantadosi
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Oxidation of nitric oxide by oxomanganese-salen complexes: a new mechanism for cellular protection by superoxide dismutase/catalase mimetics.

Authors:  Martyn A Sharpe; Richard Ollosson; Victoria C Stewart; John B Clark
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

5.  Mitochondrial transporter ATP binding cassette mitochondrial erythroid is a novel gene required for cardiac recovery after ischemia/reperfusion.

Authors:  Marc Liesa; Ivan Luptak; Fuzhong Qin; Brigham B Hyde; Ergun Sahin; Deborah A Siwik; Zhengkun Zhu; David R Pimentel; X Julia Xu; Neil B Ruderman; Karl D Huffman; Susan R Doctrow; Lauren Richey; Wilson S Colucci; Orian S Shirihai
Journal:  Circulation       Date:  2011-07-25       Impact factor: 29.690

Review 6.  Mitochondria as a therapeutic target in heart failure.

Authors:  Marina Bayeva; Mihai Gheorghiade; Hossein Ardehali
Journal:  J Am Coll Cardiol       Date:  2012-12-05       Impact factor: 24.094

Review 7.  Role of nitroso radicals as drug targets in circulatory shock.

Authors:  Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Br J Pharmacol       Date:  2009-06       Impact factor: 8.739

8.  Streptococcus pneumoniae invades erythrocytes and utilizes them to evade human innate immunity.

Authors:  Masaya Yamaguchi; Yutaka Terao; Yuka Mori-Yamaguchi; Hisanori Domon; Yuuki Sakaue; Tetsuya Yagi; Kunihiko Nishino; Akihito Yamaguchi; Victor Nizet; Shigetada Kawabata
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

Review 9.  Antioxidants improve the phenotypes of dilated cardiomyopathy and muscle fatigue in mitochondrial superoxide dismutase-deficient mice.

Authors:  Hirofumi Koyama; Hidetoshi Nojiri; Satoru Kawakami; Tadahiro Sunagawa; Takuji Shirasawa; Takahiko Shimizu
Journal:  Molecules       Date:  2013-01-24       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.